Daniel P. Larson

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

S. Vincent Rajkumar, Vikas Gupta, Rafaël Fonseca et al. · Leukemia · 2013 · 237 citations

Medicine, Genetics, Oncology +14

Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma

Reona Sakemura, Mehrdad Hefazi, Elizabeth L. Siegler et al. · Blood · 2022 · 137 citations · Full text

Medicine, Cell Biology, Oncology +17

Nonsteroidal Selective Glucocorticoid Modulators:  The Effect of C-10 Substitution on Receptor Selectivity and Functional Potency of 5-Allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines

Philip R. Kym, Michael E. Kort, Michael J. Coghlan et al. · Journal of Medicinal Chemistry · 2003 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies

Vivek Dixit, S. Quan, Paul Martin et al. · Journal of Clinical Microbiology · 1995 · 89 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Total Synthesis of Tricolorin A

Daniel P. Larson, Clayton H. Heathcock · The Journal of Organic Chemistry · 1997 · 83 citations

Pharmacy, Biochemistry, Chemistry +11